Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study.

Staaf J, Glodzik D, Bosch A, Vallon-Christersson J, Reuterswärd C, Häkkinen J, Degasperi A, Amarante TD, Saal LH, Hegardt C, Stobart H, Ehinger A, Larsson C, Rydén L, Loman N, Malmberg M, Kvist A, Ehrencrona H, Davies HR, Borg Å, Nik-Zainal S.

Nat Med. 2019 Sep 30. doi: 10.1038/s41591-019-0582-4. [Epub ahead of print]

PMID:
31570822
2.

Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series.

Vallon-Christersson J, Häkkinen J, Hegardt C, Saal LH, Larsson C, Ehinger A, Lindman H, Olofsson H, Sjöblom T, Wärnberg F, Ryden L, Loman N, Malmberg M, Borg Å, Staaf J.

Sci Rep. 2019 Aug 21;9(1):12184. doi: 10.1038/s41598-019-48570-x.

3.

Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer.

Lundgren C, Bendahl PO, Borg Å, Ehinger A, Hegardt C, Larsson C, Loman N, Malmberg M, Olofsson H, Saal LH, Sjöblom T, Lindman H, Klintman M, Häkkinen J, Vallon-Christersson J, Fernö M, Rydén L, Ekholm M.

Breast Cancer Res Treat. 2019 Aug 20. doi: 10.1007/s10549-019-05378-7. [Epub ahead of print]

PMID:
31432367
4.

Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort.

Dihge L, Vallon-Christersson J, Hegardt C, Saal LH, Häkkinen J, Larsson C, Ehinger A, Loman N, Malmberg M, Bendahl PO, Borg Å, Staaf J, Rydén L.

Clin Cancer Res. 2019 Jul 24. doi: 10.1158/1078-0432.CCR-19-0075. [Epub ahead of print]

PMID:
31340938
5.

Refinement of breast cancer molecular classification by miRNA expression profiles.

Søkilde R, Persson H, Ehinger A, Pirona AC, Fernö M, Hegardt C, Larsson C, Loman N, Malmberg M, Rydén L, Saal L, Borg Å, Vallon-Christerson J, Rovira C.

BMC Genomics. 2019 Jun 17;20(1):503. doi: 10.1186/s12864-019-5887-7.

6.

Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration.

Leung SCY, Nielsen TO, Zabaglo LA, Arun I, Badve SS, Bane AL, Bartlett JMS, Borgquist S, Chang MC, Dodson A, Ehinger A, Fineberg S, Focke CM, Gao D, Gown AM, Gutierrez C, Hugh JC, Kos Z, Laenkholm AV, Mastropasqua MG, Moriya T, Nofech-Mozes S, Osborne CK, Penault-Llorca FM, Piper T, Sakatani T, Salgado R, Starczynski J, Sugie T, van der Vegt B, Viale G, Hayes DF, McShane LM, Dowsett M; International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group (BIG-NABCG).

Histopathology. 2019 Aug;75(2):225-235. doi: 10.1111/his.13880. Epub 2019 Jul 8.

PMID:
31017314
7.

Stability of oestrogen and progesterone receptor antigenicity in formalin-fixed paraffin-embedded breast cancer tissue over time.

Ehinger A, Bendahl PO, Rydén L, Fernö M, Alkner S.

APMIS. 2018 Sep;126(9):746-754. doi: 10.1111/apm.12884.

PMID:
30160021
8.

Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative.

Rydén L, Loman N, Larsson C, Hegardt C, Vallon-Christersson J, Malmberg M, Lindman H, Ehinger A, Saal LH, Borg Å.

Br J Surg. 2018 Jan;105(2):e158-e168. doi: 10.1002/bjs.10741.

9.

Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013.

Ehinger A, Malmström P, Bendahl PO, Elston CW, Falck AK, Forsare C, Grabau D, Rydén L, Stål O, Fernö M; South and South-East Swedish Breast Cancer Groups.

Acta Oncol. 2017 Jan;56(1):68-74. doi: 10.1080/0284186X.2016.1237778. Epub 2016 Oct 20.

PMID:
27762648
10.

Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer.

Alkner S, Bendahl PO, Ehinger A, Lövgren K, Rydén L, Fernö M.

PLoS One. 2016 Mar 9;11(3):e0150977. doi: 10.1371/journal.pone.0150977. eCollection 2016.

11.

Prognosis, stage and oestrogen receptor status of contralateral breast cancer in relation to characteristics of the first tumour, prior endocrine treatment and radiotherapy.

Alkner S, Ehinger A, Bendahl PO, Rydén L, Fernö M.

Eur J Cancer. 2015 Nov;51(16):2304-13. doi: 10.1016/j.ejca.2015.07.016. Epub 2015 Aug 1.

PMID:
26243193
12.

Contralateral breast cancer can represent a metastatic spread of the first primary tumor: determination of clonal relationship between contralateral breast cancers using next-generation whole genome sequencing.

Alkner S, Tang MH, Brueffer C, Dahlgren M, Chen Y, Olsson E, Winter C, Baker S, Ehinger A, Rydén L, Saal LH, Fernö M, Gruvberger-Saal SK.

Breast Cancer Res. 2015 Aug 5;17:102. doi: 10.1186/s13058-015-0608-x.

13.

The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine.

Saal LH, Vallon-Christersson J, Häkkinen J, Hegardt C, Grabau D, Winter C, Brueffer C, Tang MH, Reuterswärd C, Schulz R, Karlsson A, Ehinger A, Malina J, Manjer J, Malmberg M, Larsson C, Rydén L, Loman N, Borg Å.

Genome Med. 2015 Feb 2;7(1):20. doi: 10.1186/s13073-015-0131-9. eCollection 2015.

14.

The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer.

Kolkova Z, Casslén V, Henic E, Ahmadi S, Ehinger A, Jirström K, Casslén B.

J Ovarian Res. 2012 Mar 18;5:9. doi: 10.1186/1757-2215-5-9.

15.

Acute pancreatitis evoked by small-cell lung carcinoma metastases and detected by endoscopic ultrasound.

Wurm Johansson G, Toth E, Torp J, Ehinger A, Andersson L, Thorlacius H.

Endoscopy. 2012;44 Suppl 2 UCTN:E45-6. doi: 10.1055/s-0031-1291523. Epub 2012 Mar 6. No abstract available.

PMID:
22396272
16.

G protein-coupled estrogen receptor 1 (GPER, GPR 30) in normal human endometrium and early pregnancy decidua.

Kolkova Z, Noskova V, Ehinger A, Hansson S, Casslén B.

Mol Hum Reprod. 2010 Oct;16(10):743-51. doi: 10.1093/molehr/gaq043. Epub 2010 May 27.

PMID:
20508064
17.

Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wall.

Styring E, Fernebro J, Jönsson PE, Ehinger A, Engellau J, Rissler P, Rydholm A, Nilbert M, Vult von Steyern F.

Breast Cancer Res Treat. 2010 Aug;122(3):883-7. doi: 10.1007/s10549-009-0703-8. Epub 2010 Jan 20.

PMID:
20087653
18.
19.

Histamine uptake by human endometrial cells expressing the organic cation transporter EMT and the vesicular monoamine transporter-2.

Noskova V, Bottalico B, Olsson H, Ehinger A, Pilka R, Casslén B, Hansson SR.

Mol Hum Reprod. 2006 Aug;12(8):483-9. Epub 2006 Mar 27.

PMID:
16567367
20.

Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.

Nordengren J, Pilka R, Noskova V, Ehinger A, Domanski H, Andersson C, Høyer-Hansen G, Hansson SR, Casslén B.

Mol Hum Reprod. 2004 Sep;10(9):655-63. Epub 2004 Jul 8.

PMID:
15243126
21.

In vitro and in vivo correlation of buserelin release from biodegradable implants using statistical moment analysis.

Schliecker G, Schmidt C, Fuchs S, Ehinger A, Sandow J, Kissel T.

J Control Release. 2004 Jan 8;94(1):25-37.

PMID:
14684269
22.

AWD 12-281, a highly selective phosphodiesterase 4 inhibitor, is effective in the prevention and treatment of inflammatory reactions in a model of allergic dermatitis.

Bäumer W, Gorr G, Hoppmann J, Ehinger AM, Rundfeldt C, Kietzmann M.

J Pharm Pharmacol. 2003 Aug;55(8):1107-14.

PMID:
12956900
23.

Effects of the phosphodiesterase 4 inhibitors SB 207499 and AWD 12-281 on the inflammatory reaction in a model of allergic dermatitis.

Bäumer W, Gorr G, Hoppmann J, Ehinger AM, Ehinger B, Kietzmann M.

Eur J Pharmacol. 2002 Jun 20;446(1-3):195-200.

PMID:
12098602
24.

Concentration of enrofloxacin and its metabolite ciprofloxacin in canine matrices of the locomotor system.

Ehinger AM, Meyer-Lindenberg A, Vick M, Nolte I, Kietzmann M.

J Vet Med A Physiol Pathol Clin Med. 2002 Mar;49(2):99-104.

PMID:
11958474
25.

[Pharmacokinetics of cephalexin from two oral formulations in dogs].

Ehinger AM, Kietzmann M.

Berl Munch Tierarztl Wochenschr. 2002 Jan-Feb;115(1-2):57-61. German.

PMID:
11852685
26.

[The tissue distribution of antibiotics in the udder--comparison of the situation in vivo with the isolated perfused bovine udder].

Ehinger AM, Kietzmann M.

Dtsch Tierarztl Wochenschr. 2001 May;108(5):195-200. Review. German.

PMID:
11417377
28.

[Pharmacokinetics of kanamycin after subcutaneous and intravenous administration in dogs].

Calvo Wieland A, Ehinger AM, Kietzmann M, Nolte I.

Berl Munch Tierarztl Wochenschr. 2001 Jan-Feb;114(1-2):57-60. German.

PMID:
11225500
29.
30.

Tissue distribution of oxacillin and ampicillin in the isolated perfused bovine udder.

Ehinger AM, Kietzmann M.

J Vet Med A Physiol Pathol Clin Med. 2000 Apr;47(3):157-68.

PMID:
10842465
31.

Effects of the phosphodiesterase 4 inhibitor RPR 73401 in a model of immunological inflammation.

Ehinger AM, Gorr G, Hoppmann J, Telser E, Ehinger B, Kietzmann M.

Eur J Pharmacol. 2000 Mar 24;392(1-2):93-9.

PMID:
10748277
32.

[Pharmacokinetic aspects of mastitis therapy].

Ehinger AM, Kietzmann M.

Berl Munch Tierarztl Wochenschr. 1998 Sep;111(9):337-43. Review. German.

PMID:
9789371
33.

Sequence, organization and expression of the core histone genes of Aspergillus nidulans.

Ehinger A, Denison SH, May GS.

Mol Gen Genet. 1990 Jul;222(2-3):416-24.

PMID:
2274040
34.

Epidemic of aseptic meningitis associated with ECHO virus type 9.

WESSLEN T, ERIKSSON S, EHINGER A, ZETTERBERG B.

Arch Gesamte Virusforsch. 1958;8(2):183-91. No abstract available.

PMID:
13545786

Supplemental Content

Loading ...
Support Center